The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis

Background: We aimed to investigate the change of hepatitis B virus (HBV) viral loads and HBV reactivation (HBVr) in rheumatoid arthritis (RA) patients after tapering the dose of biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs). Methods: This two-center analysis retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Der-Yuan, Chen, Hsin-Hua, Chang, Shih-Hsin, Chen, Yi-Ming, Huang, Po-Hao, Hsieh, Chia-Wei, Lan, Joung-Liang, Tang, Kuo-Tung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821696/
https://www.ncbi.nlm.nih.gov/pubmed/36614890
http://dx.doi.org/10.3390/jcm12010086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821696/
https://www.ncbi.nlm.nih.gov/pubmed/36614890
http://dx.doi.org/10.3390/jcm12010086

Ejemplares similares